Publications by authors named "Yuri Yuguchi"

Claim this Profile
R
Response to First-Line Chemotherapy Predicts Response to Maintenance Avelumab Therapy in Japanese Patients With Advanced Urothelial Carcinoma.
Satoshi Inoue, Akira Hayakawa, Mikinori Kobayashi, Yuriko Nagasaka, Takanao Omi, Yuri Yuguchi

Int J Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-related skin reactions in enfortumab vedotin as a surrogate marker of survival and treatment response.
Jun Nagayama, Satoshi Inoue, Hiroki Sai, Akira Hayakawa, Yuri Yuguchi

Int J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.
Takayuki Owaki, Tadashi Iida, Yuki Miyai, Katsuhiro Kato, Tetsunari Hase, Yuri Yuguchi

Br J Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between the number of lymph nodes dissected and prognosis in muscle-invasive bladder cancer in the era of neoadjuvant chemotherapy.
Kosuke Tochigi, Jun Nagayama, Shoko Bando, Akinobu Ishiyama, Takuma Yuba, Yuri Yuguchi

Int J Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial Cancer.
Satoshi Inoue, Naoto Sassa, Hideji Kawanishi, Yuri Yuguchi, Tomohide Suzuki

Anticancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of constipation predicts the therapeutic efficacy of pembrolizumab in metastatic urothelial cancer patients.
Satoshi Inoue, Naoto Sassa, Takashi Kato, Yushi Yamauchi, Tsuyoki Hirabayashi, Yuri Yuguchi

Int J Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical benefit of sequential therapy with androgen receptor axis-targeted agents alone in patients with castration-resistant prostate cancer: A propensity score-matched comparison study.
Yushi Naito, Masashi Kato, Hideji Kawanishi, Yuri Yuguchi, Takuma Yuba

Prostate· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis